Research SpotlightCommunity Spotlight Hope and Action for Down syndrome Alzheimer’s research on WDSD 2023 Each year, the Down syndrome community and our supporters – family, friends, businesses, organizations and…Kate O’NeillMarch 21, 2023
Community Spotlight An athlete’s heart and a charmer’s smile: meet Armond Maillard March 21st is “Down Syndrome Awareness Day,” a day designated by the United Nations to…Kate O’NeillMarch 17, 2023
Community Spotlight Beyond Down Syndrome: The Friedman family turns experience into guidance Parent, advocate, and published author, Steve Friedman has used his family's recent experiences to help…Kate O’NeillMarch 15, 2023
Research SpotlightResearch News Fierce Biotech article highlights dearth of inclusion in Alzheimer’s research "Alzheimer's meds are here. But for the Down syndrome community, it's still the 1980s" by…Kate O’NeillMarch 2, 2023
Research SpotlightPress ReleaseResearch News With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research 2/22/2023 (Burlington, MA) – Today the LuMind IDSC Foundation, a leading national Down syndrome research…Kate O’NeillFebruary 23, 2023
Research SpotlightCommunity Spotlight Statement on accelerated approval of Leqembi to treat mild-stage Alzheimer’s disease in the general population On Friday, January 6, the U.S. Food & Drug Administration (FDA) granted accelerated approval for…Kate O’NeillJanuary 10, 2023
Research NewsResearch Spotlight New steps forward in treating Alzheimer’s disease with lecanemab: Clinical trial reveals clear efficacy in removing brain plaque At an Alzheimer’s disease research conference last week, new clinical trial data was presented for…Kate O’NeillDecember 5, 2022
Press ReleaseResearch Spotlight DS-CTN Data and Safety Monitoring Board (DSMB) LuMind IDSC and the Down Syndrome Clinical Trials Network are pleased to announce the launch…Kate O’NeillNovember 16, 2022
Research Spotlight Lecanemab: New Treatment for Alzheimer’s Disease Eisai, a Japanese pharmaceutical company, and its partner Biogen, a Massachusetts-based biotechnology company, recently announced…Kate O’NeillNovember 1, 2022
Research Spotlight NTG Publishes Advisory on Long-COVID in Adults with Intellectual Disability In a recent report, the National Task Group on Intellectual Disabilities and Dementia Practices (NTG)…Kate O’NeillOctober 17, 2022